pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Virginia Commonwealth University

updated 5mo ago

Virginia Commonwealth University (VCU) is a public research university in Richmond, Virginia, United States. VCU was founded in 1838 as the medical department of Hampden–Sydney College, becoming the Medical College of Virginia (MCV) in 1854. In 1968, the Virginia General Assembly merged MCV with the Richmond Professional Institute, founded in 1917, to create Virginia Commonwealth University. In 2025, more than 29,280 students were enrolled in more than 200 academic programs, and 23 VCU programs were ranked among U.S. News & World Report’s top 50 best college programs.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagALS1 co-mentions · 1 sources
  • tagAsthma1 co-mentions · 1 sources
  • tagType 2 Diabetes1 co-mentions · 1 sources
  • drugcisplatin1 co-mentions · 1 sources
  • drugPRV-2111 co-mentions · 1 sources
  • drugcisplatin SR1 co-mentions · 1 sources
  • drugiCIP1 co-mentions · 1 sources
  • tagDermatology1 co-mentions · 1 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0

Pipeline(0)

no pipeline products on record

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase3De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipientscompletedn=30
  • —Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extensionrecruitingn=1,000
  • N/AEffectiveness of the Eko Digital Stethoscope in Capturing Infant ECGscompletedn=91
  • phase2Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Caactive not recruitingn=46
  • N/AAlveolar Ridge Preservation (ARP) in the Posterior Maxilla After the Extraction of Maxillary Molarsrecruitingn=40
  • phase2Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Carecruitingn=83
  • N/AComparing the Attentional Demands and Functional Outcomes in People With Transradial Amputationrecruitingn=32
  • phase1Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinomanot yet recruitingn=20
🐶 Hiring Signal
No open roles indexed yet — view Virginia Commonwealth University jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
mentioned in
0news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?